Management of front line chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Management of front line chronic lymphocytic leukemia

Published:2022-09-20 Issue:S2 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Kutsch Nadine¹^ORCID,Fink Anna Maria¹,Fischer Kirsten¹

Affiliation:

1. Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne, Duesseldorf and German CLL Study Group University of Cologne Cologne Germany

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26677

Reference80 articles.

1. Surveillance Epidemiology and End Result Program (SEER) of the National Cancer Institute.Cancer stat facts: NHL ‐ chronic lymphiocytic leukemia.2022. Accessed May 04 2022.https://seer.cancer.gov/statfacts/html/cllsll.html

2. Prognostic factors in chronic lymphocytic leukemia—what do we need to know?

3. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data

4. A CONTINUOUS INDIVIDUALIZED RISK INDEX FOR REFINED OUTCOME PREDICTION AFTER TARGETED THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CIRI‐CLL)

5. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mice Overexpressing Wild-Type RRAS2 Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies;Cancers;2023-12-12

2. Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey;Children;2023-04-19